Literature DB >> 32813900

What Will it Take to Move the Needle for Headache Disorders? An Advocacy Perspective.

Robert E Shapiro1.   

Abstract

Discrimination toward people living with migraine and other headache disorders is widespread and socially accepted. Stigma toward these diseases is both a manifestation of these discriminatory attitudes and a sustainer of them. For those living with migraine and headache disorders, stigma limits the full expression of their lives, as well as the likelihood of receiving health care to reduce the burden. In the past decade, public advocacy organizations have emerged in the United States and internationally to counter the consequences of this stigma. These organizations have raised public awareness of these diseases, corrected misconceptions, and empowered millions of people affected by them. The Alliance for Headache Disorders Advocacy has focused on addressing the structural stigma inherent in discriminatory policies of employers, government agencies, and public institutions. While notable progress has been made, there is considerable work left to be done to increase resources and equity for people living with headache disorders.
© 2020 American Headache Society.

Entities:  

Keywords:  National Institutes of Health; advocacy; headache; migraine; presenteeism; stigma

Year:  2020        PMID: 32813900     DOI: 10.1111/head.13913

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  7 in total

Review 1.  Outpatient Approach to Resistant and Refractory Migraine in Children and Adolescents: a Narrative Review.

Authors:  Alison Marshall; Rebecca Lindsay; Michelle A Clementi; Amy A Gelfand; Serena L Orr
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-26       Impact factor: 6.030

2.  Learning the full impact of migraine through patient voices: A qualitative study.

Authors:  Paige M Estave; Summerlyn Beeghly; Reid Anderson; Caitlyn Margol; Mariam Shakir; Geena George; Anissa Berger; Nathaniel O'Connell; Rebecca Burch; Niina Haas; Scott W Powers; Elizabeth Seng; Dawn C Buse; Richard B Lipton; Rebecca Erwin Wells
Journal:  Headache       Date:  2021-06-03       Impact factor: 5.311

Review 3.  The status of neurology fellowships in the United States: clinical needs, educational barriers, and future outlooks.

Authors:  Matthew S Robbins; Stefano Sandrone; Harini Sarva; Gustavo A Patino; Mehmood Rashid; James W M Owens
Journal:  BMC Med Educ       Date:  2021-02-17       Impact factor: 2.463

4.  One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey.

Authors:  Timothy J Steiner; Messoud Ashina; Thien Phu Do; Simon Stefansen; Mikala Dømgaard
Journal:  J Headache Pain       Date:  2022-07-18       Impact factor: 8.588

Review 5.  Migraine in the workplace.

Authors:  Olivia Begasse de Dhaem; Fumihiko Sakai
Journal:  eNeurologicalSci       Date:  2022-06-06

6.  Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability.

Authors:  Edoardo Caronna; Victor José Gallardo; Alicia Alpuente; Marta Torres-Ferrus; Patricia Pozo-Rosich
Journal:  J Neurol       Date:  2021-07-20       Impact factor: 4.849

7.  Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial.

Authors:  Scott W Powers; Christopher S Coffey; Leigh A Chamberlin; Dixie J Ecklund; Elizabeth A Klingner; Jon W Yankey; James L Peugh; Leslie L Korbee; Kerry Simmons; Stephanie M Sullivan; Marielle A Kabbouche; Joanne Kacperski; Linda L Porter; Brooke L Reidy; Andrew D Hershey
Journal:  JAMA Netw Open       Date:  2021-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.